As of 2024-12-11, the Relative Valuation of Coherus BioSciences Inc (CHRS) is (0.10) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.61 USD, the upside of Coherus BioSciences Inc based on Relative Valuation is -106.5%.
The range of the Relative Valuation is (0.08) - (0.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.0x - 35.7x | 26.7x |
| Forward P/E multiples | 20.3x - 34.7x | 26.8x |
| Fair Price | (0.08) - (0.14) | (0.10) |
| Upside | -104.9% - -108.4% | -106.5% |
| Date | P/E |
| 2024-12-10 | -412.20 |
| 2024-12-09 | -435.24 |
| 2024-12-06 | -435.24 |
| 2024-12-05 | -386.59 |
| 2024-12-04 | -437.80 |
| 2024-12-03 | -437.80 |
| 2024-12-02 | -350.75 |
| 2024-11-29 | -312.35 |
| 2024-11-27 | -322.59 |
| 2024-11-26 | -327.71 |
| 2024-11-25 | -309.79 |
| 2024-11-22 | -279.06 |
| 2024-11-21 | -281.62 |
| 2024-11-20 | -281.62 |
| 2024-11-19 | -210.32 |
| 2024-11-18 | -200.03 |
| 2024-11-15 | -190.48 |
| 2024-11-14 | -197.80 |
| 2024-11-13 | -199.36 |
| 2024-11-12 | -210.83 |
| 2024-11-11 | -199.39 |
| 2024-11-08 | -208.66 |
| 2024-11-07 | -209.94 |
| 2024-11-06 | -185.31 |
| 2024-11-05 | -187.15 |
| 2024-11-04 | -171.53 |
| 2024-11-01 | -185.10 |
| 2024-10-31 | -190.74 |
| 2024-10-30 | -191.99 |
| 2024-10-29 | -190.33 |
| 2024-10-28 | -184.72 |
| 2024-10-25 | -200.72 |
| 2024-10-24 | -203.31 |
| 2024-10-23 | -207.38 |
| 2024-10-22 | -220.54 |
| 2024-10-21 | -224.22 |
| 2024-10-18 | -226.04 |
| 2024-10-17 | -217.16 |
| 2024-10-16 | -226.99 |
| 2024-10-15 | -233.01 |
| 2024-10-14 | -240.43 |
| 2024-10-11 | -253.51 |
| 2024-10-10 | -248.50 |
| 2024-10-09 | -256.02 |
| 2024-10-08 | -266.26 |
| 2024-10-07 | -273.94 |
| 2024-10-04 | -266.26 |
| 2024-10-03 | -266.26 |
| 2024-10-02 | -261.14 |
| 2024-10-01 | -261.14 |